-

Naturmega’s SUPRIAX2™ Solution to Make Its North American Debut at SupplySide Global 2026

Powered by Ruby-O® technology, SUPRIAX2™ signals a new frontier in omega-3 innovation, one defined by intentional lipid design beyond source alone.

BARRANQUILLA, Colombia--(BUSINESS WIRE)--Naturmega, an advanced lipid science company specializing in omega-3 and next-generation lipid technologies, will introduce SUPRIAX2™ to the North American market at SupplySide Global 2026 in Las Vegas. The ingredient is the first market-ready solution within Naturmega’s BeyondKrill™ territory, reflecting the company’s vision for the next frontier of omega-3 innovation: moving beyond source and concentration toward intentional lipid design.

Naturmega’s SUPRIAX2™ will make its North American debut at SupplySide Global. The shellfish-free phospholipid omega-3 ingredient delivers 450 mg of EPA+DHA and approximately twice the omega-3 strength of conventional krill oil.

Share

For decades, omega-3 innovation has largely focused on where omega-3 comes from and how highly it can be concentrated. Naturmega believes the next evolution will be defined by how lipids are designed, structured and delivered.

SUPRIAX2™ brings that vision to market through Ruby-O® bonded phospholipid technology, which bonds omega-3 fatty acids to phospholipids rather than simply blending the two components. The result is a differentiated ingredient designed to offer brands greater potency, formulation versatility and a more consumer-friendly experience.

“The omega-3 category has spent decades asking where omega-3 comes from and how highly it can be concentrated. We believe the next question is how intelligently it can be designed and delivered,” said Jorge Atencio, Chief Operating Officer at Naturmega. “BeyondKrill™ represents that next frontier, and SUPRIAX2™ is the first market-ready expression of this lipid-design approach.”

Moving Beyond Source

SUPRIAX2™ delivers 450 mg of EPA and DHA per suggested daily serving, offering approximately twice the omega-3 strength of conventional krill oil and a higher amount of omega-3 bonded to phospholipids. It is also shellfish-free and features a neutral sensory profile, addressing formulation and consumer-experience challenges commonly associated with krill-based products.

SUPRIAX2™ is powered by Ruby-O®, Naturmega’s proprietary lipid-design platform. Ruby-O® uses an enzymatic process to create omega-3 fatty acids bonded to phospholipids, producing a structured lipid system designed to give brands greater flexibility in developing products around specific nutritional, formulation and positioning objectives.

The Ruby-O® platform is supported by clinical research examining how its bonded phospholipid structure may influence omega-3 delivery and incorporation. Early findings indicate potential advantages compared with conventional fish oil, while additional research is underway to further evaluate the relationship between lipid structure, phospholipid delivery and omega-3 utilization.

Market-Ready Solutions and What Comes Next

The North American introduction of SUPRIAX2™ will anchor Naturmega’s broader presence at SupplySide Global, where the company will showcase two complementary solution platforms.

Essential Solutions address the immediate needs of brands seeking reliable, scalable and application-ready omega-3 ingredients, including improved sensory performance, marine and algal sourcing, supply resilience, higher concentrations and greater format flexibility.

Next-Generation Solutions use intentional lipid design, emerging science and proprietary technology platforms to help brands create differentiated products for the future of nutritional health.

Beyond SUPRIAX2™, visitors will be able to explore Ruby-O® bonded phospholipid technology; SENSES™ for a clearer, more neutral omega-3 experience; Algalis® algal DHA; Dualis™ dual-origin marine and algal omega-3; and the EssentiOmega® portfolio of scalable omega-3 solutions.

Naturmega will also present application concepts demonstrating how advanced lipid ingredients can move beyond traditional formats into gummies, powders, beverages, purées, gels, chewables and softgels.

Brands do not all come to us with the same challenge, some need a better sensory experience, a different source, supply flexibility or an ingredient that can move immediately into commercialization. Others are looking for a truly differentiated platform that can define their next generation of products. Naturmega is structured to support both.” Joel Minski, Chief Strategy Officer at Naturmega.

Meet Naturmega at SupplySide Global

Naturmega will exhibit at SupplySide Global 2026 in Las Vegas at booth 6643. Attendees are invited to meet the company’s commercial, scientific and innovation teams, experience its latest application concepts and explore opportunities to develop differentiated omega-3 products.

To schedule a meeting or request information, visit Naturmega.com or contact info@naturmega.com.

About Naturmega

Naturmega is an advanced lipid science company redefining how omega-3 and specialized lipids are designed, manufactured and brought to market. From high-quality marine and algal omega-3 ingredients to proprietary bonded phospholipid technologies, Naturmega combines scientific expertise, advanced manufacturing and application development to help brands create differentiated and commercially viable products.

Through its Essential Solutions and Next-Generation Solutions platforms, Naturmega supports brands and CDMOs with both market-ready ingredients and emerging lipid technologies designed to shape what comes next in nutritional health.

For more information, visit www.naturmega.com.

Contacts

Rosella Del Vecchio info@naturmega.com

Naturmega


Release Versions

Contacts

Rosella Del Vecchio info@naturmega.com

Social Media Profiles
More News From Naturmega

Naturmega® Announces Peer-Reviewed Clinical Results for Ruby-O® Balance, Demonstrating Stronger Triglyceride Responder Outcomes with a Lower Omega-3 Dose

BARRANQUILLA, Colombia--(BUSINESS WIRE)--New peer-reviewed clinical research examines the role of omega-3 delivery architecture in triglyceride outcomes and omega-3 incorporation....
Back to Newsroom